肝硬化门静脉血栓形成的优选治疗方法：抗凝还是经颈静脉肝内门体分流术？ - Suppr

Suppr

超能文献

The preferable treatment for cirrhotic portal vein thrombosis: anticoagulation or transjugular intrahepatic portosystemic shunt?

作者信息

Qi Xingshun, Han Guohong, Fan Daiming

出版信息

Hepatology. 2010 Feb;51(2):713-4. doi: 10.1002/hep.23217.

DOI:10.1002/hep.23217

PMID:20104582

Abstract

摘要

相似文献

The preferable treatment for cirrhotic portal vein thrombosis: anticoagulation or transjugular intrahepatic portosystemic shunt?

Hepatology. 2010 Feb;51(2):713-4. doi: 10.1002/hep.23217.

Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.

Liver Int. 2012 Jul;32(6):919-27. doi: 10.1111/j.1478-3231.2012.02785.x. Epub 2012 Mar 21.

[Chronic liver disease and thrombosis risk].

Duodecim. 2015;131(4):321-30.

Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without underlying cirrhosis.

Cardiovasc Intervent Radiol. 2007 May-Jun;30(3):545; author reply 546. doi: 10.1007/s00270-006-0321-3.

Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis.

Cardiovasc Intervent Radiol. 2006 Sep-Oct;29(5):785-90. doi: 10.1007/s00270-005-0090-4.

Portal vein thrombosis.

Clin Liver Dis. 2015 Feb;19(1):199-221. doi: 10.1016/j.cld.2014.09.012. Epub 2014 Oct 30.

Portal Vein Thrombosis in Cirrhosis.

J Clin Gastroenterol. 2017 Aug;51(7):579-585. doi: 10.1097/MCG.0000000000000834.

[Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].

Zhonghua Yi Xue Za Zhi. 2009 Jun 9;89(22):1549-52.

Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis.

Dig Liver Dis. 2017 Dec;49(12):1345-1352. doi: 10.1016/j.dld.2017.05.020. Epub 2017 Jun 27.

Portal vein thrombosis.

Am J Med. 2010 Feb;123(2):111-9. doi: 10.1016/j.amjmed.2009.05.023.

引用本文的文献

Case report: Management of liver cancer complicated by gastric varices rupture and bleeding: transjugular intrahepatic portosystemic shunt utilizing the mesenteric venous pathway.

Front Med (Lausanne). 2024 Jun 19;11:1388584. doi: 10.3389/fmed.2024.1388584. eCollection 2024.

Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis.

World J Gastroenterol. 2017 Nov 7;23(41):7470-7477. doi: 10.3748/wjg.v23.i41.7470.

Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant).

Medicine (Baltimore). 2017 Nov;96(45):e8498. doi: 10.1097/MD.0000000000008498.

An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty.

Arch Med Sci. 2016 Dec 1;12(6):1381-1383. doi: 10.5114/aoms.2016.62921. Epub 2016 Oct 24.

Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature.

Hepatol Int. 2012 Jun;6(3):576-90. doi: 10.1007/s12072-011-9324-5. Epub 2011 Dec 1.

Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial.

BMJ Open. 2013 Jul 11;3(7). doi: 10.1136/bmjopen-2013-003370. Print 2013.

Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.

Med Sci Monit. 2012 Aug;18(8):HY37-41. doi: 10.12659/msm.883252.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验